TSC-100 and TSC-101, TCR-T Cell Therapies That Target Residual Recipient Cells after Reduced Intensity Conditioning Transplantation, Induce Complete Donor Chimerism with Favorable Prognosis: Early Results of a Phase 1 Trial

Autor: Al Malki, Monzr M., Keyzner, Alla, Suh, Hyung C., Popat, Uday R., Dwivedi, Nishant, Kothari, Ashish S, Buonomo, Erica, Wang, Yun, Abelowitz, Nina, Murray, Jim, MacBeath, Gavin, Barton, Debora, Chattopadhyay, Shrikanta, Reshef, Ran
Zdroj: In Transplantation and Cellular Therapy February 2024 30(2) Supplement:S1-S2
Databáze: ScienceDirect
Externí odkaz: